Enfusion Inc.

11.10
-0.04 (-0.36%)
At close: Mar 28, 2025, 3:59 PM
11.00
-0.90%
After-hours: Mar 28, 2025, 05:29 PM EDT

Enfusion Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Revenue 201.61M 174.53M 150.35M 111.7M 79.56M 59.03M
Cost of Revenue 64.87M 57.64M 47.1M 31.84M 21.36M 16.96M
Gross Profit 136.74M 116.89M 103.25M 79.86M 58.21M 42.07M
Operating Income 6.16M 11.95M -11.96M -275.88M 6.07M 13.87M
Interest Income 1.69M n/a 413K 4.59M 1.66M 724K
Pretax Income 7.39M 11.48M -12.19M -281.66M 4.49M 13.14M
Net Income 2.82M 6.03M -13.26M -282.24M 4.06M 12.66M
Selling & General & Admin 103.86M 85.05M 98.05M 202.34M 45.81M 24.05M
Research & Development 26.73M 19.89M 17.16M 153.4M 6.32M 4.15M
Other Expenses n/a n/a -638K -1.19M 82K -3K
Operating Expenses 130.58M 104.95M 115.21M 355.74M 52.13M 28.2M
Interest Expense n/a n/a 413K 4.59M 1.66M 724K
Selling & Marketing Expenses 25.03M 20.42M 29.29M 51.73M 9.93M 7.43M
Cost & Expenses 195.46M 162.59M 162.31M 387.58M 73.49M 45.16M
Income Tax 4.57M 2.23M 1.07M 579K 433K 486K
Shares Outstanding (Basic) 92.05M 88.2M 85.39M 65.58M 113.05M 113.05M
Shares Outstanding (Diluted) 129.55M 129.43M 85.39M 65.58M 113.05M 113.05M
EPS (Basic) 0.02 0.10 -0.16 -4.3 0.04 0.11
EPS (Diluted) 0.01 0.07 -0.16 -4.3 0.04 0.11
EBITDA 6.16M 21.93M -5.62M -271.91M 8.37M 15.02M
Depreciation & Amortization n/a 9.99M 6.6M 3.98M 2.29M 1.16M